Sterling Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
Sterling Capital Management's CLB Position: Q3 2026 in Review
Sterling Capital Management reduced its Core Laboratories (CLB) stake by 3.9% in Q3 2026, selling an estimated $428 and leaving 902 shares worth $8.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2585.
Sterling Capital Management first reported a position in CLB in Q4 2013 and has held it in 16 quarters since. The position peaked at $37.3M in Q3 2019. 92 funds tracked by Wall St. Rank hold CLB as of Q3 2026.
- Sterling Capital Management held 902 shares of Core Laboratories worth $8.75K as of Q3 2026.
- Sterling Capital Management sold 37 Core Laboratories shares in Q3 2026, an estimated $428.
- Core Laboratories made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2585 holding.
- Sterling Capital Management first reported a position in Core Laboratories in Q4 2013 and has held it in 16 quarters since.
- Sterling Capital Management's Core Laboratories position peaked at $37.3M in Q3 2019.
- 92 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.